Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report

Abstract Immune checkpoint inhibitors can often trigger immune‐related adverse events (irAEs), such as relapse of pre‐existing interstitial pneumonia. Here, we report the case of an 88‐year‐Japanese man diagnosed with advanced lung adenocarcinoma with a high tumor proportion score of programmed deat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Motoyasu Kato, Mikiko Mori, Keita Miura, Tetsuhiko Asao, Hiroaki Motomura, Koichi Nishino, Ryo Ko, Ryo Koyama, Takuo Hayashi, Kazuhisa Takahashi
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
Accès en ligne:https://doaj.org/article/16663f7f5c7349c497012a0c4953698f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!